Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22-25 April 2013, Krakow, Poland.

Shurin MR, Umansky V, Malyguine A, Hurwitz AA, Apte RN, Whiteside T, Jewett A, Thanavala Y, Murphy WJ.

Cancer Immunol Immunother. 2014 Jan;63(1):73-80. doi: 10.1007/s00262-013-1501-z. Epub 2013 Nov 24. No abstract available.

PMID:
24271210
2.

Cancer immunotherapy and immunomonitoring (CITIM): redefining cancer therapy.

Malyguine A, Umansky V, Shurin MR.

J Immunotoxicol. 2009 Dec;6(4):205-8. doi: 10.3109/15476910903120932.

PMID:
19908938
3.

Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): moving forward.

Malyguine A, Umansky V, Kotlan B, Aptsiauri N, Shurin MR.

J Immunotoxicol. 2012 Jul-Sep;9(3):231-5. doi: 10.3109/1547691X.2012.686930. Epub 2012 May 29.

PMID:
22639903
4.

From cell regulation to patient survival: 2nd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, Budapest, 2-5 May 2011.

Umansky V, Malyguine A, Kotlan B, Aptsiauri N, Shurin MR.

Cancer Immunol Immunother. 2012 Feb;61(2):295-301. doi: 10.1007/s00262-011-1115-2. Epub 2011 Sep 28. No abstract available.

PMID:
21953053
5.

Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia.

Aptsiauri N, Jewett A, Hurwitz AA, Shurin MR, Umansky V.

Cancer Immunol Immunother. 2016 Jul;65(7):875-83. doi: 10.1007/s00262-016-1795-8. Epub 2016 Jan 25. No abstract available.

PMID:
26810566
6.

CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.

Diken M, Attig S, Grunwitz C, Kranz L, Simon P, van de Roemer N, Vascotto F, Kreiter S.

Hum Vaccin Immunother. 2013 Sep;9(9):2025-32. doi: 10.4161/hv.25768. Epub 2013 Jul 22.

7.

Immunotherapy at the American Association for Cancer Research 95th annual meeting: a personal impression.

Guinn BA.

Cancer Immunol Immunother. 2005 Mar;54(3):290-5. Epub 2004 Sep 14. No abstract available.

PMID:
15372206
8.

Dendritic cell vaccination and other strategies to tip the balance of the immune system : DC2007 5th International Meeting, July 16-18, Bamberg, Germany.

Schaft N, Birkholz K, Hofmann C, Schmid M, Theiner G, Dörrie J.

Cancer Immunol Immunother. 2008 Jun;57(6):913-28. doi: 10.1007/s00262-007-0443-8. Epub 2008 Jan 31. No abstract available.

PMID:
18236041
9.

Radiation-enhanced immune response to cancer: workshop, Anaheim, CA, April 17, 2005.

Sutherland RM.

Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):3-5. No abstract available.

PMID:
16377408
10.

[Molecular mechanisms of tumor and immune system interaction].

Berezhnoĭ AE, Gnuchev NV, Georgiev GP, Kozlov AM, Larin SS.

Vopr Onkol. 2008;54(6):669-83. Review. Russian. No abstract available.

PMID:
19241839
12.

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention.

Whiteside TL.

Semin Cancer Biol. 2006 Feb;16(1):3-15. Epub 2005 Sep 8. Review.

PMID:
16153857
13.

Universal and stemness-related tumor antigens: potential use in cancer immunotherapy.

Parmiani G, Russo V, Marrari A, Cutolo G, Casati C, Pilla L, Maccalli C, Rivoltini L, Castelli C.

Clin Cancer Res. 2007 Oct 1;13(19):5675-9. No abstract available.

14.

Tumor immunology and the Battle of Waterloo.

Acres B, Beverley P, Scholl S.

Mol Cancer Ther. 2002 Jun;1(8):651-5. No abstract available.

15.

Combination of radiofrequency ablation and immunotherapy.

Fagnoni FF, Zerbini A, Pelosi G, Missale G.

Front Biosci. 2008 Jan 1;13:369-81. Review.

PMID:
17981554
16.

[Cancer treatment by comprehensive regulation of anti-tumor immune network].

Kawakami Y.

Nihon Rinsho. 2010 Jun;68(6):1094-9. Review. Japanese.

PMID:
20535961
17.

Cancer therapy-induced immune modulation.

Karl JC, Mackall CL.

Cancer Chemother Biol Response Modif. 2005;22:325-41. Review. No abstract available.

PMID:
16110619
18.

Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunology.

Laheru DA, Pardoll DM, Jaffee EM.

Mol Cancer Ther. 2005 Nov;4(11):1645-52. Review.

19.

Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear.

Dimberu PM, Leonhardt RM.

Yale J Biol Med. 2011 Dec;84(4):371-80. Review.

20.

Targeting Foxp3+ regulatory T cells-related immunosuppression for cancer immunotherapy.

Feng LL, Wang X.

Chin Med J (Engl). 2010 Nov;123(22):3334-42. Review. Erratum in: Chin Med J (Engl). 2011 Jun;124(12):1884.

Items per page

Supplemental Content

Write to the Help Desk